Diffusion Tensor Imaging of the Optic Tracts in Multiple Sclerosis: Association with Retinal Thinning and Visual Disability

Journal of Neuroimaging

Volumn 21, Issue 2, 2011, Pages

  Dasenbrock, Hormuzdiyar H ^a   Smith, Seth A ^b,d   Ozturk, Arzu ^b   Farrell, Sheena K ^c   Calabresi, Peter A ^c   Reich, Daniel S ^b,c,d  

^a Transportation Research Institute   (United States)

^b Department of Radiology and Radiological Science ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Diffusion tensor imaging; Magnetic resonance imaging; Multiple sclerosis; Optic neuritis; Optic tract; Optical coherence tomography

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; MALE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; OPTIC TRACT; OPTICAL COHERENCE TOMOGRAPHY; RETINA; RETINA MACULA LUTEA; RETINA NERVE CELL; TRACTOGRAPHY; VISUAL ACUITY; VISUAL DISORDER; WHITE MATTER;

ADULT; AGED; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; VISUAL ACUITY; VISUAL PATHWAYS;

EID: 79953042175     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2010.00468.x     Document Type: Article

References (60)

1. McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry 1992;55:747-752.
2. Sorensen TL, Frederiksen JL, Bronnum-Hansen H, et al. Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey. Neurology 1999;53:473-478.
3. Ma SL, Shea JA, Galetta SL, et al. Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire. Am J Ophthalmol 2002;133:686-692.
4. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
5. Balcer LJ, Baier ML, Cohen JA, et al. Contrast letter acuity as a visual component for the multiple sclerosis functional composite. Neurology 2003;61:1367-1373.
6. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122(Pt 5):871-882.
7. Balcer LJ. Optic neuritis. N Engl J Med 2006;354:1273-1280.
8. Sisto D, Trojano M, Vetrugno M, et al. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. Invest Ophthalmol Vis Sci 2005;46:1264-1268.
9. Rosenblatt MA, Behrens MM, Zweifach PH, et al. Magnetic resonance imaging of optic tract involvement in multiple sclerosis. Am J Ophthalmol 1987;104:74-79.
10. Plant GT, Kermode AG, Turano G, et al. Symptomatic retrochiasmal lesions in multiple sclerosis: clinical features, visual evoked potentials, and magnetic resonance imaging. Neurology 1992;42:68-76.
11. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002;15:239-245.
12. Rovaris M, Filippi M. Diffusion tensor MRI in multiple sclerosis. J Neuroimaging 2007;17(Suppl 1):27S-30S.
13. Fox RJ. Picturing multiple sclerosis: conventional and diffusion tensor imaging. Semin Neurol 2008;28:453-466.
14. Reich DS, Zackowski KM, Gordon-Lipkin EM, et al. Corticospinal tract abnormalities are associated with weakness in multiple sclerosis. AJNR Am J Neuroradiol 2008;29:333-339.
15. Warlop NP, Achten E, Debruyne J, et al. Diffusion weighted callosal integrity reflects interhemispheric communication efficiency in multiple sclerosis. Neuropsychologia 2008;46:2258-2264.
16. Warlop NP, Fieremans E, Achten E, et al. Callosal function in MS patients with mild and severe callosal damage as reflected by diffusion tensor imaging. Brain Res 2008;1226:218-225.
17. Trip SA, Schlottmann PG, Jones SJ, et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 2006;31:286-293.
18. Wu GF, Schwartz ED, Lei T, et al. Relation of vision to global and regional brain MRI in multiple sclerosis. Neurology 2007;69:2128-2135.
19. Hickman SJ, Wheeler-Kingshott CA, Jones SJ, et al. Optic nerve diffusion measurement from diffusion-weighted imaging in optic neuritis. AJNR Am J Neuroradiol 2005;26:951-956.
20. Naismith RT, Xu J, Tutlam NT, et al. Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology 2009;72:589-594.
21. Kolbe S, Chapman C, Nguyen T, et al. Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis. Neuroimage 2009;45:679-686.
22. Vinogradov E, Degenhardt A, Smith D, et al. High-resolution anatomic, diffusion tensor, and magnetization transfer magnetic resonance imaging of the optic chiasm at 3T. J Magn Reson Imaging 2005;22:302-306.
23. Reich DS, Smith SA, Gordon-Lipkin EM, et al. Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. Arch Neurol 2009;66:998-1006.
24. Staempfli P, Rienmueller A, Reischauer C, et al. Reconstruction of the human visual system based on DTI fiber tracking. J Magn Reson Imaging 2007;26:886-893.
25. Zhang J, Jones M, DeBoy CA, et al. Diffusion tensor magnetic resonance imaging of Wallerian degeneration in rat spinal cord after dorsal root axotomy. J Neurosci 2009;29:3160-3171.
26. Budde MD, Kim JH, Liang HF, et al. Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR Biomed 2008;21:589-597.
27. Kerrison JB, Flynn T, Green WR. Retinal pathologic changes in multiple sclerosis. Retina 1994;14:445-451.
28. Evangelou N, Konz D, Esiri MM, et al. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 2001;124:1813-1820.
29. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005;58:383-391.
30. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006;113:324-332.
31. Pulicken M, Gordon-Lipkin E, Balcer LJ, et al. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 2007;69:2085-2092.
32. Gordon-Lipkin E, Chodkowski B, Reich DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007;69:1603-1609.
33. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006;59:963-969.
34. Grazioli E, Zivadinov R, Weinstock-Guttman B, et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci 2008;268:12-17.
35. Pueyo V, Martin J, Fernandez J, et al. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler 2008;14:609-614.
36. Henderson AP, Trip SA, Schlottmann PG, et al. An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 2008;131:277-287.
37. Ogden TE. Nerve fiber layer of the primate retina: thickness and glial content. Vision Res 1983;23:581-587.
38. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285.
39. Ferguson B, Matyszak MK, Esiri MM, et al. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120(Pt 3):393-399.
40. De Stefano N, Matthews PM, Fu L, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998;121(Pt 8):1469-1477.
41. Baier ML, Cutter GR, Rudick RA, et al. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology 2005;64:992-995.
42. Balcer LJ, Baier ML, Pelak VS, et al. New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis. Mult Scler 2000;6:163-171.
43. Toledo J, Sepulcre J, Salinas-Alaman A, et al. Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis. Mult Scler 2008;14:906-912.
44. Owsley C, Sloane ME. Contrast sensitivity, acuity, and the perception of 'real-world' targets. Br J Ophthalmol 1987;71:791-796.
45. Balcer LJ, Galetta SL, Calabresi PA, et al. Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology 2007;68:1299-1304.
46. Reich DS, Smith SA, Jones CK, et al. Quantitative characterization of the corticospinal tract at 3T. AJNR Am J Neuroradiol 2006;27:2168-2178.
47. Landman BA, Farrell JA, Jones CK, et al. Effects of diffusion weighting schemes on the reproducibility of DTI-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5T. Neuroimage 2007;36:1123-1138.
48. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143-155.
49. Woods RP, Grafton ST, Watson JD, et al. Automated image registration: II. Intersubject validation of linear and nonlinear models. J Comput Assist Tomogr 1998;22:153-165.
50. Mori S, Crain BJ, Chacko VP, et al. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 1999;45:265-269.
51. Jiang H, van Zijl PC, Kim J, et al. DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed 2006;81:106-116.
52. Reich DS, Smith SA, Zackowski KM, et al. Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. Neuroimage 2007;38:271-279.
53. Farrell JAD. Q-space diffusion imaging of axon and myelin damage in the human and rat spinal cord. PhD thesis Baltimore, MD: Johns Hopkins University, 2009.
54. Roosendaal SD, Geurts JJ, Vrenken H, et al. Regional DTI differences in multiple sclerosis patients. Neuroimage 2009;44:1397-1403.
55. Wheeler-Kingshott CA, Cercignani M. About "axial" and "radial" diffusivities. Magn Reson Med 2009;61:1255-1260.
56. Sergott RC, Frohman E, Glanzman R, et al. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci 2007;263:3-14.
57. Rovaris M, Judica E, Ceccarelli A, et al. A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS. J Neurol 2008;255:1209-1214.
58. Smith SA, Williams ZR, Reich DS, et al. Diffusion tensor and magnetization transfer MRI of the in vivo, human optic nerve correlates with retinal nerve fiber layer thickness in multiple sclerosis. Am Acad Neurol (Seattle, WA) 2009.
59. Rosner B. Fundamentals of Biostatistics. 6th ed. Belmont, CA: Thomson Higher Education, 2006.
60. Alexander AL, Hasan KM, Lazar M, et al. Analysis of partial volume effects in diffusion-tensor MRI. Magn Reson Med 2001;45:770-780.